
 |
5-HTP Plus Formula by Douglas Labs 60 Vegetarian Capsules
A Proprietary Blend Of 5-HTP And P-5-P
| Our Price: $37.60 | 
|
5-HTP Plus Formula capsules, provided by Douglas Laboratories, contain 75 mg of natural L-5-hydroxytryptophan (5-HTP) extracted from seeds of the Griffonia plant, together with 7.5 mg of pyridoxal-5-phosphate and 50 mg of a proprietary blend of the neurotransmitters L-tyrosine and L-glutamine.* Serotonin, an important brain neurotransmitter, is key in the regulation of appetite, mood, and melatonin production. The presence of serotonin in the brain is associated with a balanced emotional state. This is achieved in part by decreasing the activity of certain excitatory hormones, including dopamine and noradrenaline. Serotonin also acts as a satiety signal in the brain, thereby naturally regulating food intake. Additionally, as a precursor of melatonin, serotonin is involved in regulating sleep patterns. Serotonin is unable to cross the blood-brain barrier and is therefore synthesized in the brain.* Tryptophan, an essential amino acid, is a precursor for the synthesis of serotonin. Tryptophan crosses the blood-brain barrier and is converted to L-5-hydroxytryptophan, which inturn is converted into serotonin. Unfortunately, tryptophan faces many obstacles during its journey* into brain tissue. First, dietary intake directly affects body levels of tryptophan, as the body can not endogenously produce it. High protein diets often provide greater amounts of tryptophan, yet higher carbohydrate diets appear to enhance tryptophan uptake into the brain. Secondly, tryptophan must compete with other amino acids for entry into the brain. Finally, tryptophan may be taken up by other tissues for protein or niacin synthesis, and thus is not exclusively for use by the brain. As a metabolic intermediate in the conversion of tryptophan into serotonin, 5-HTP can also serve as a precursor of serotonin.* 5-HTP offers a number of advantages over tryptophan. 5-HTP is derived naturally from the seeds of the Griffonia plant, unlike tryptophan which is produced synthetically or through bacterial fermentation. 5-HTP crosses into the brain more readily than tryptophan as it is able to cross the blood-brain barrier without competition for uptake. 5-HTP is significantly more effective than tryptophan; one 50 mg capsule of 5-HTP is roughly equivalent to 500 mg of tryptophan. Finally, research studies have shown 5-HTP to be safe at levels as high as 900 mg. As a result, 5-HTP is a safe and effective means of increasing brain serotonin level.* Vitamin B6 is necessary for the conversion of 5-HTP to Serotonin. Thus an adequate intake of vitamin B6 is necessary to dreive optimal benefits of 5-HTP.*
|
|
Supplement FactsServing Size: One (1) Vegetarian Capsule Servings Per Container: 60 | | | | Amount Per Serving | Daily Value | L-5-Hydroxytryptophan (L-5-HTP) (Griffonia Seed Extract) | 75 mg | ** | | Pyridoxal 5' Phosphate | 7.5 mg | ** | A Proprietary Blend L-tyrosine and L-glutamine | 50 mg | ** | | ** Daily Value Not Established. Percent Daily Values are based on a 2,000 calorie diet. |
|
 |
|
| This product has been certified to be free of a contaminant, peak "x", implicated in a past incidence of dietary tryptophan-associated eosinophilia myalgia syndrome (EMS).* |
 |
| As a dietary supplement, adults take One (1) Capsule daily or as directed by a physician. |
 |
| KEEP OUT OF REACH OF CHILDREN. ... Store in a cool, dry place, away from direct light. |
 |
| This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring. |
 |
|
| Appetite - Decreasing, Brain Chemistry, Food Addiction, Mood Swings, Neural Calm, Sleep Disturbance, Sleeplessness |
 |
| Brain, Nerve, Nervous System, Neurologic Tissue |
 |
Abraham GE, Rumley RE. Role of nutrition in managing the premenstrual tension syndromes. J Reprod Med 1987;32:405-22.
Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutr 2000;19:3-12.
Daugherty JE. Treatment strategies for premenstrual syndrome. Am Fam Physician 1998;58:183-92, 197-8.
de la Gandara Martin JJ, de Diego Herrero E. [Premenstrual dysphoric disorder: an epidemiological study]. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1996;24:111-7.
Kornstein SG, Parker AJ. Menstrual migraines: etiology, treatment, and relationship to premenstrual syndrome. Curr Opin Obstet Gynecol 1997;9:154-9.
Lenzinger E, Diamant K, Vytiska-Binstorfer E, et al. [Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches]. Nervenarzt 1997;68:708-18.
Singh BB, Berman BM, Simpson RL, et al. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med 1998;4:75-9.
Ugarriza DN, Klingner S, O'Brien S. Premenstrual syndrome: diagnosis and intervention. Nurse Pract 1998;23:40, 45, 49-52 passim. Ward MW, Holimon TD. Calcium treatment for premenstrual syndrome. Ann Pharmacother 1999;33:1356-8.
Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment ofpremenstrual syndrome: systematic review [see comments]. Bmj 1999;318:1375-81. |
 |
 |
Our Price: $37.60 |

|
|
|
|